Patrizia Giannatempo, Medical Oncology Consultant specializing in urological cancers at the National Cancer Institute (INT), shared a post on X:
“Amazing session on testicular cancer!
So exciting to see new therapeutic approaches on the horizon. CAR T-cells, ADCs, and bispecifics targeting Claudin 6 – the future is bright!”
